Advanced Animal Diagnostics

Cover Block

Field	Value
Name	Advanced Animal Diagnostics
Tagline	Develops on-farm diagnostic tests for livestock health to boost productivity and cut antibiotic use
Headquarters	Morrisville, North Carolina
Founded	2001
Stage	Series C
Business Model	B2B
Industry	Agtech
Technology	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	$40.5M total disclosed

Links

• Website: https://www.qscoutlab.com/
• LinkedIn: https://www.linkedin.com/company/advanced-animal-diagnostics

Executive Summary

Advanced Animal Diagnostics (AAD) is a Morrisville, North Carolina biotech company building point-of-care blood diagnostic tests for cattle and dairy cows. The mission is to enable selective treatment of sick animals rather than dosing entire herds with antibiotics [Advanced Animal Diagnostics website].

Founded in 2001 by Rudy Rodriguez, a 40-year medical-devices veteran who previously ran R&D for BD Worldwide's Primary Care Diagnostics Division, the company is led by president and CEO Joy Parr Drach [Advanced Animal Diagnostics website] [Bloomberg]. Its core platform, QScout, delivers a white blood cell count and differential at the chute or in the milking parlor in roughly two minutes from a single drop of blood. It has two productized variants: QScout BLD for beef cattle and QScout MLD for subclinical mastitis in dairy cows [Advanced Animal Diagnostics website].

AAD has raised approximately $40.5 million, including a $15 million Series C. The syndicate includes Novartis Venture Fund, Cultivian, Intersouth Partners, Middleland Capital, LabCorp, Alexandria Venture Investments, Murphy Family Ventures and Mountain Group Partners [PR Newswire]. Commercial validation includes a partnership with Zoetis covering international distribution of the QScout MLD test outside the United States [PR Newswire] [North Carolina Biotechnology Center].

Data Accuracy: GREEN -- Confirmed by company website, PR Newswire, Bloomberg, and North Carolina Biotechnology Center.

Taxonomy Snapshot

Axis	Value
Stage	Series C
Business Model	B2B
Industry / Vertical	Agtech, livestock diagnostics
Technology Type	Biotech / Life Sciences, point-of-care hematology
Geography	North America (HQ), international distribution via Zoetis
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding	$40.5M total disclosed

How the Company Got Here

Advanced Animal Diagnostics was founded in 2001 in North Carolina's Research Triangle. Operations are based in Morrisville [Advanced Animal Diagnostics website]. The founding premise was to translate human-medicine hematology into a ruggedized, on-farm form factor.

Rudy Rodriguez, who came out of BD's Primary Care Diagnostics group after fifteen years as VP of R&D, anchored the engineering effort. Joy Parr Drach, now president and CEO, has led the company through its commercial-stage years [Advanced Animal Diagnostics website] [Bloomberg].

The product family is branded QScout. Public materials name three variants: QScout BLD for cattle health screening, QScout MLD for early detection of subclinical mastitis in dairy cows, and QScout RLD, a human-health hematology analyzer being commercialized through affiliate Ad Astra Diagnostics under a 510(k) clearance pathway [Advanced Animal Diagnostics website].

Notable milestones include a commercial partnership with Zoetis to market QScout MLD in the United States, with a subsequent license and commercialization agreement for international distribution rights outside the US [North Carolina Biotechnology Center] [PR Newswire]. The most recent disclosed financing event was a $15 million Series C, bringing cumulative disclosed funding to roughly $40.5 million [PR Newswire] [CB Insights].

Data Accuracy: GREEN -- Confirmed by company website, Bloomberg, PR Newswire, and North Carolina Biotechnology Center.

Product and Technology

AAD's core technology is a point-of-care hematology platform performing a white blood cell count and differential from a drop of blood in roughly two minutes [Advanced Animal Diagnostics website].

QScout BLD is positioned for use at feedlot arrival. By measuring immune-system signatures, QScout BLD aims to identify the subset of cattle that genuinely need treatment [Advanced Animal Diagnostics website]. The company reports that, in a feedlot trial, antibiotic use on arrival fell by 87% versus the metaphylaxis baseline. Claimed economics are $148,000 to $218,000 in saved treatment cost per 10,000 head at $17 to $25 per treatment [PR Newswire].

QScout MLD targets subclinical mastitis. AAD reports that selective dry cow therapy guided by QScout MLD produced a 47% reduction in antibiotic use at the cow level and 59% at the quarter level at dryoff. A single-farm case study at Son-Bow Farms describes a 6 lb per cow increase in average milk production after deploying the test on heifers [Advanced Animal Diagnostics website] [Agweb].

Zoetis holds both US marketing rights and international commercialization rights to the MLD test [North Carolina Biotechnology Center] [PR Newswire].

QScout RLD extends the hematology engine into human point-of-care use. The company says it has secured 510(k) clearance for the QScout hematology analyzer [Advanced Animal Diagnostics website].

Data Accuracy: YELLOW -- Product features confirmed across company site and PR Newswire; efficacy metrics rely primarily on company-distributed materials.

Market Research and Opportunity

Livestock diagnostics sits at the intersection of antimicrobial-resistance regulation and the productivity squeeze on commercial beef and dairy.

In US beef, roughly 25 to 30 million head of cattle move through feedlots each year. The company's trial economics, $148,000 to $218,000 in saved treatment cost per 10,000 head [PR Newswire], imply a multi-hundred-million-dollar annual savings pool.

In dairy, mastitis is the single most expensive disease in commercial herds. The Zoetis partnership signals that a credible animal-health incumbent views the QScout MLD opportunity as material [PR Newswire] [North Carolina Biotechnology Center].

Metric	Value
Antibiotic reduction on arrival, feedlot trial	87%
Per-10,000-head cost savings, feedlot trial	$148,000 - $218,000
Antibiotic reduction at dryoff, cow level	47%
Antibiotic reduction at dryoff, quarter level	59%
Milk yield uplift, Son-Bow Farms case	+6 lb per cow

Data Accuracy: YELLOW -- Trial economics and product claims confirmed via company and PR Newswire; broader market sizing is contextual.

Competitive Landscape

AAD competes against do-nothing protocols, lab-based reference testing, and the diagnostic arms of large animal-health incumbents.

The competitive map breaks into four bands: status-quo protocols (blanket metaphylaxis/dry-cow therapy), lab-based diagnostic workflows, in-line milk monitoring systems, and captive R&D portfolios of large animal-health firms. Zoetis is today AAD's distribution partner rather than a competitor [PR Newswire] [North Carolina Biotechnology Center].

AAD's edge is the two-minute, single-drop, point-of-care white blood cell differential. This generates a quantitative, auditable record at the animal level [Advanced Animal Diagnostics website]. The Zoetis license-and-commercialization agreement gives AAD a global distribution channel it could not realistically build on $40.5 million of cumulative funding [PR Newswire].

Data Accuracy: YELLOW -- Partnership structure and product positioning confirmed via PR Newswire and North Carolina Biotechnology Center; competitive map is analyst inference.

Opportunity

The size of the prize is to become the default point-of-care hematology layer for both livestock and ambulatory human medicine on a single analyzer platform.

Scenario	What happens	Catalyst	Why it's plausible
Dairy default in EU/Oceania	QScout MLD becomes standard tool	Zoetis international rollout	EU restrictions on prophylactic antimicrobials [PR Newswire]
Feedlot protocol shift	Top-five US feeder adopts QScout BLD	Independent replication of trial result	Feedlot trial economics of $148K-$218K per 10,000 head [PR Newswire]
Human point-of-care crossover	QScout RLD becomes sepsis-triage tool	Post-clearance commercial launch	510(k) clearance reported [Advanced Animal Diagnostics website]

Data Accuracy: YELLOW -- Scenario logic anchored in confirmed Zoetis partnership, reported 510(k) clearance, and company-disclosed trial economics.

Sources

1. [Advanced Animal Diagnostics] Advanced Animal Diagnostics homepage | https://www.qscoutlab.com/
2. [Advanced Animal Diagnostics] AAD Beef | https://www.qscoutlab.com/beef
3. [Advanced Animal Diagnostics] QScout BLD Feedlot Trial Results | https://www.qscoutlab.com/feedlot-trial
4. [Advanced Animal Diagnostics] AgBio Initiative | https://www.qscoutlab.com/agbio
5. [Advanced Animal Diagnostics] Ad Astra Diagnostics receives 510(k) clearance for QScout hematology analyzer | https://www.qscoutlab.com/clearance
6. [Advanced Animal Diagnostics] AAD Our People | https://www.qscoutlab.com/our-people
7. [Advanced Animal Diagnostics] AAD Careers | https://www.qscoutlab.com/careers
8. [Advanced Animal Diagnostics] AAD Board & Investors | https://www.qscoutlab.com/board-investors
9. [Advanced Animal Diagnostics] Diagnose subclinical mastitis with QScout MLD test | https://www.qscoutlab.com/dairy
10. [Advanced Animal Diagnostics] Human Health | https://www.qscoutlab.com/human-health
11. [Advanced Animal Diagnostics] Seeing The Proof | https://www.qscoutlab.com/seeing-the-proof
12. [Advanced Animal Diagnostics] AAD Announces New Board Members | https://www.qscoutlab.com/new-board-members
13. [LinkedIn] Advanced Animal Diagnostics company page | https://www.linkedin.com/company/advanced-animal-diagnostics
14. [Bloomberg] Joy Parr Drach, Advanced Animal Diagnostics profile | https://www.bloomberg.com/profile/person/17217690
15. [CB Insights] Advanced Animal Diagnostics company profile | https://www.cbinsights.com/company/advanced-animal-diagnostics
16. [PR Newswire] Advanced Animal Diagnostics announcements (Series C, Zoetis license) | https://www.prnewswire.com/
17. [North Carolina Biotechnology Center] AAD partners with Zoetis to market QScout MLD | https://www.ncbiotech.org/
18. [Agweb] Son-Bow Farms case study on QScout MLD | https://www.agweb.com/